Ureaplasma urealyticum and chronic lung disease in very low birth weight infants during the exogenous surfactant era

被引:36
作者
Perzigian, RW
Adams, JT
Weiner, GM
Dipietro, MA
Blythe, LK
Pierson, CL
Faix, RG
机构
[1] Univ Michigan, Dept Pediat, Med Ctr, Sect Neonatal Perinatal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Med Ctr, Dept Radiol, Sect Pediat Radiol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Med Ctr, Dept Pathol, Clin Microbiol Lab, Ann Arbor, MI 48109 USA
关键词
Ureaplasma; bronchopulmonary dysplasia; surfactant; airway; very low birth weight infant;
D O I
10.1097/00006454-199807000-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background An association between recovery of Ureaplasma urealyticum from the respiratory tract of very low birth weight (VLBW) infants (less than or equal to 1500 g) and later chronic lung disease (CLD) was reported by several authors before the routine use of exogenous surfactant (SURF). We sought to assess whether this relation persists in the era of routine SURF. Methods. We prospectively studied a cohort of 105 VLBW infants who required mechanical ventilation at <12 h of age. Tracheal aspirates for U. urealyticum culture were obtained before administration of SURF or antibiotics. Clinicians were unaware of U. urealyticum status. Chest radiographs at 28 days were reviewed by a single pediatric radiologist, blinded to U, urealyticum status. Sample size was predetermined to detect a 30% increase in CLD among those with U. urealyticum recovery from tracheal culture (U. urealyticum-positive) with alpha < 0.05 and beta <0.20. Results. Of the study infants 22 were U, urealyticum-positive and 83 were U. urealyticum-negative. No differences were found between the groups for birth weight, gestational age, gender, inborn, antenatal or postnatal steroid use, SURF therapy, non-U. urealyticum infection, necrotizing enterocolitis, patent ductus arteriosus, intraventricular hemorrhage or cystic periventricular leukomalacia. At 28 days U. urealyticum-positive patients were significantly more likely to have CLD than U. urealyticum-negative [15 of 22 (68%) vs. 30 of 83 (36%); P < 0.02]. The U. urealyticum-positive patients also required significantly longer courses of supplemental oxygen and mechanical ventilation. No significant differences were found for CLD at 36 weeks postconception or duration of hospitalization, although type II error could not be excluded for these secondary endpoints. Conclusions. Respiratory U. urealyticum at or shortly after birth remains associated with CLD at 28 days despite routine use of SURF. Controlled trials of anti-Ureaplasma therapy in U. urealyticum-positive VLBWs as soon after birth as possible may determine whether CLD, duration of respiratory support and attendant costs can be decreased.
引用
收藏
页码:620 / 625
页数:6
相关论文
共 34 条
[1]   UREAPLASMA UREALYTICUM IN NEWBORN AND PREMATURE-INFANTS - ASSOCIATION WITH BRONCHOPULMONARY DYSPLASIA [J].
ABELEHORN, M ;
HENTSCHEL, J .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (11) :408-414
[2]  
ABZUG MJ, 1991, J REPROD MED, V36, P783
[3]  
Blanchard A., 1993, CLIN INFECT DIS S1, V17, P148
[4]  
CASSELL GH, 1988, LANCET, V2, P240
[5]  
CASSELL GH, 1986, PEDIAT INFECT DIS, pS247
[6]  
CORDERO L, 1996, RESP CARE, V41, P22
[7]  
CROUSE DT, 1995, J PEDIATR-US, V126, P502, DOI 10.1016/S0022-3476(95)70486-8
[8]   Comparison of culture with the polymerase chain reaction for detection of Ureaplasma urealyticum in endotracheal aspirates of preterm infants [J].
Cunliffe, NA ;
Fergusson, S ;
Davidson, F ;
Ross, PW .
JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 45 (01) :27-30
[9]   Role of Ureaplasma urealyticum and Chlamydia trachomatis in development of bronchopulmonary dysplasia in very low birth weight infants [J].
DaSilva, O ;
Gregson, D ;
Hammerberg, O .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (04) :364-369
[10]   UREAPLASMA-UREALYTICUM IN A NEONATAL INTENSIVE-CARE POPULATION [J].
DYKE, MP ;
GRAUAUG, A ;
KOHAN, R ;
OTT, K ;
ANDREWS, R .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1993, 29 (04) :295-297